Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial.

Ulf Näslund,Nawi Ng,Anna Lundgren,Eva Fhärm,Christer Grönlund,Helene Johansson,Bernt Lindahl,Bertil Lindahl,Kristina Lindvall,Stefan K Nilsson,Maria Nordin,Steven Nordin,Emma Nyman,Joacim Rocklöv,Davide Vanoli,Lars Weinehall,Patrik Wennberg,Per Wester,Margareta Norberg

The Lancet（2019）

引用 129|浏览47

暂无评分

摘要

Västerbotten County Council, the Swedish Research Council, the Heart and Lung Foundation, the Swedish Society of Medicine, and Carl Bennet Ltd, Sweden.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要